UnitedHealth Group (UNH), buoyed by growth potential of its expanding pharmacy benefit business, raised its earnings outlook with the coming addition of a much larger drug management operation. The nation’s […]

Marilyn Tavenner is about to make an unprecedented move: From head of Medicare, to the nation’s top lobbyist for private insurers — in just six months. Tavenner will succeed Karen […]

NEW YORK, NY and LONDON, UNITED KINGDOM–(Marketwired – July 13, 2015) – Celsus Therapeutics (NASDAQ: CLTX) and Volution Immuno Pharmaceuticals SA today announced that they have entered into a Definitive […]

As the larger Aetna (AET) looks to the future following its proposed acquisition of Humana (HUM), one key area under consideration would be to bring the management of its large […]

The big are getting bigger: Aetna and Humana, the nation’s number three and number four health insurers by revenue, are merging. Aetna will pay about $230 per share for Humana, […]

HARTFORD, Conn. & LOUISVILLE, Ky.–(BUSINESS WIRE)–Aetna (NYSE: AET) and Humana Inc. (NYSE: HUM) today announced that they have entered into a definitive agreement under which Aetna will acquire all outstanding […]

CHICAGO, IL and LA JOLLA, CA–(Marketwired – Jul 1, 2015) – Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the acquisition and development of enhanced therapeutics for […]

Just when you think a biotech bear market is about to descend, the bulls come rushing in. News of a Greek default depressed markets yesterday and was only compounded by fears […]

External models of R&D innovation are the rage in Pharma today, as they should be – the future of our industry depends on a great deal more rather than less […]

Call it conspicuous consumption. Serial acquirer Valeant Pharmaceuticals, an anointed stock in the portfolios of some of the largest hedge funds in Manhattan, appears to be on the prowl for a […]